NYSE:HCP - HCP Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$29.88 +0.07 (+0.23 %)
(As of 01/18/2019 04:00 PM ET)
Previous Close$29.81
Today's Range$29.60 - $29.97
52-Week Range$21.48 - $30.26
Volume3.50 million shs
Average Volume3.33 million shs
Market Capitalization$14.12 billion
P/E Ratio15.32
Dividend Yield4.98%
Beta0.28
HCP, Inc. is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.

Receive HCP News and Ratings via Email

Sign-up to receive the latest news and ratings for HCP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Real estate investment trusts
Sub-IndustrySpecialized REITs
SectorFinance
CUSIP40414L10
Phone949-407-0700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.85 billion
Cash Flow$2.0954 per share
Book Value$11.93 per share

Profitability

Net Income$414.16 million

Miscellaneous

Employees190
Market Cap$14.12 billion
OptionableOptionable

HCP (NYSE:HCP) Frequently Asked Questions

What is HCP's stock symbol?

HCP trades on the New York Stock Exchange (NYSE) under the ticker symbol "HCP."

How often does HCP pay dividends? What is the dividend yield for HCP?

HCP announced a quarterly dividend on Thursday, October 25th. Stockholders of record on Monday, November 5th will be paid a dividend of $0.37 per share on Tuesday, November 20th. This represents a $1.48 annualized dividend and a dividend yield of 4.95%. The ex-dividend date is Friday, November 2nd. View HCP's Dividend History.

How were HCP's earnings last quarter?

HCP, Inc. (NYSE:HCP) issued its quarterly earnings data on Wednesday, October, 31st. The real estate investment trust reported $0.21 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.11 by $0.10. The real estate investment trust earned $456 million during the quarter, compared to analyst estimates of $456.59 million. HCP had a return on equity of 3.06% and a net margin of 9.16%. HCP's quarterly revenue was up .4% on a year-over-year basis. During the same period in the previous year, the firm earned $0.48 EPS. View HCP's Earnings History.

When is HCP's next earnings date?

HCP is scheduled to release their next quarterly earnings announcement on Tuesday, February 12th 2019. View Earnings Estimates for HCP.

What guidance has HCP issued on next quarter's earnings?

HCP updated its FY18 earnings guidance on Wednesday, October, 31st. The company provided earnings per share (EPS) guidance of $1.79-1.83 for the period, compared to the Thomson Reuters consensus estimate of $1.82.

What price target have analysts set for HCP?

16 analysts have issued 1 year price targets for HCP's stock. Their forecasts range from $21.00 to $33.00. On average, they anticipate HCP's share price to reach $27.3929 in the next year. This suggests that the stock has a possible downside of 8.3%. View Analyst Price Targets for HCP.

What is the consensus analysts' recommendation for HCP?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HCP in the last year. There are currently 2 sell ratings, 6 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for HCP.

What are Wall Street analysts saying about HCP stock?

Here are some recent quotes from research analysts about HCP stock:
  • 1. According to Zacks Investment Research, "HCP third-quarter 2018 funds from operations (FFO) as adjusted of 44 cents surpassed the Zacks Consensus Estimate. However, the bottom line fell short of the prior-year tally of 48 cents. Further, revenues missed the Zacks Consensus Estimate. Notably, a 6.3% decrease in senior-housing operating portfolio cash net operating income (NOI) marred results. The company has undertaken portfolio-repositioning measures by selling assets in its portfolio. Although such efforts are a strategic fit for the long term, the dilutive impact on earnings in the near term from these dispositions are unavoidable. Further, softness in the seniors housing market fundamentals amid new supply is anticipated to thwart the company’s pricing power. Although shares of HCP have outperformed the industry it belongs to over the past year, the stock has limited upside potential given lack of positive estimate revisions." (11/13/2018)
  • 2. Cantor Fitzgerald analysts commented, "We are initiating coverage of HCP with a $28 price target and a Neutral rating. HCP has risen by 16% over the past three months, along with other large-cap REITs, but it is down 17.5% over the past year, compared with a 14% gain in the 12% decline in the S&P U.S. Healthcare REIT Index. We believe that most of the stock’s relative weakness reflects concern about interest rates, deteriorating fundamentals in senior housing and HCP’s restructuring. With HCP’s restructuring nearly at an end, we expect investors to begin valuing the company more on its fundamentals, which we expect to improve, and to worry less about interest rates. Although we think senior housing could remain slow for awhile, we are enthusiastic about HCP’s strategy to leverage its position in life science and MOB." (8/7/2018)

Has HCP been receiving favorable news coverage?

Press coverage about HCP stock has trended positive on Friday, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. HCP earned a coverage optimism score of 2.8 on InfoTrie's scale. They also gave news articles about the real estate investment trust a news buzz of 5.0 out of 10, indicating that recent news coverage is somewhat likely to have an impact on the stock's share price in the near future.

Are investors shorting HCP?

HCP saw a increase in short interest in December. As of December 14th, there was short interest totalling 24,300,535 shares, an increase of 183.0% from the November 30th total of 8,588,144 shares. Based on an average daily volume of 5,185,218 shares, the days-to-cover ratio is currently 4.7 days. Currently, 5.2% of the company's stock are short sold. View HCP's Current Options Chain.

Who are some of HCP's key competitors?

Who are HCP's key executives?

HCP's management team includes the folowing people:
  • Mr. Thomas M. Herzog, Pres, CEO & Director (Age 55)
  • Mr. Peter A. Scott, Exec. VP & CFO (Age 38)
  • Mr. Thomas M. Klaritch, Exec. VP & COO (Age 60)
  • Mr. Troy E. McHenry, Exec. VP, Gen. Counsel & Corp. Sec. (Age 45)
  • Mr. Scott M. Brinker, Exec. VP & Chief Investment Officer (Age 41)

Who are HCP's major shareholders?

HCP's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Resolution Capital Ltd (1.33%), Timbercreek Investment Management Inc. (0.10%), State of Alaska Department of Revenue (0.06%), LGT Capital Partners LTD. (0.04%), Nisa Investment Advisors LLC (0.02%) and DNB Asset Management AS (0.01%). Company insiders that own HCP stock include Kendall K Young, R Kent Griffin Jr, Scott A Anderson and Thomas Klaritch. View Institutional Ownership Trends for HCP.

Which institutional investors are selling HCP stock?

HCP stock was sold by a variety of institutional investors in the last quarter, including Timbercreek Investment Management Inc., Resolution Capital Ltd, LGT Capital Partners LTD., Oakbrook Investments LLC, Louisiana State Employees Retirement System, First Midwest Bank Trust Division, Curbstone Financial Management Corp and Global Trust Asset Management LLC. View Insider Buying and Selling for HCP.

Which institutional investors are buying HCP stock?

HCP stock was purchased by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Joel Isaacson & Co. LLC, Nisa Investment Advisors LLC, DNB Asset Management AS, First Hawaiian Bank, Curbstone Financial Management Corp, Lourd Capital LLC and Contravisory Investment Management Inc.. Company insiders that have bought HCP stock in the last two years include Kendall K Young and R Kent Griffin Jr. View Insider Buying and Selling for HCP.

How do I buy shares of HCP?

Shares of HCP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is HCP's stock price today?

One share of HCP stock can currently be purchased for approximately $29.88.

How big of a company is HCP?

HCP has a market capitalization of $14.12 billion and generates $1.85 billion in revenue each year. The real estate investment trust earns $414.16 million in net income (profit) each year or $1.95 on an earnings per share basis. HCP employs 190 workers across the globe.

What is HCP's official website?

The official website for HCP is http://www.hcpi.com.

How can I contact HCP?

HCP's mailing address is 1920 MAIN STREET SUITE 1200, IRVINE CA, 92614. The real estate investment trust can be reached via phone at 949-407-0700 or via email at [email protected]


MarketBeat Community Rating for HCP (NYSE HCP)

Community Ranking:  1.6 out of 5 (star)
Outperform Votes:  333 (Vote Outperform)
Underperform Votes:  684 (Vote Underperform)
Total Votes:  1,017
MarketBeat's community ratings are surveys of what our community members think about HCP and other stocks. Vote "Outperform" if you believe HCP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HCP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel